In the last few years, there is growing evidence of the impact of microorganic activity inside the human body. The gut microbiome is an important and significant area of interest for the healthcare industry. In this report, you will learn about five innovative gut microbiome startups.
Out of 132, the Global Startup Heat Map highlights 5 Top Gut Microbiome Startups
Startups such as the examples highlighted in this report focus on microbiome test kits, oral therapeutics, microbiota reports, and microbiome R&D platforms. While all of these technologies play a significant role in advancing healthcare, they only represent the tip of the iceberg. This time, you get to discover five hand-picked gut microbiome startups.
The Global Startup Heat Map below reveals the geographical distribution of 132 exemplary startups & scaleups we analyzed for this research. Further, it highlights five healthcare startups that we hand-picked based on scouting criteria such as founding year, location, funding raised, and more. You get to explore the solutions of these five startups & scaleups in this report. For insights on the other 127 gut microbiome startups, get in touch with us.
Click to download
Unseen Bio develops Microbiome Test Kits
Founding Year: 2018
Location: Copenhagen, Denmark
Work with Unseen Bio for Gut Bacteria Optimization
Danish startup Unseen Bio creates microbiome test kits for maintaining and optimizing gut bacteria. Its personal test kit, Digital Gut, provides a complete analysis of gut bacteria. This enables users to view the biodiversity of their gut, and levels of beneficial, non-beneficial, and selected probiotic bacteria. It also gives personal diet recommendations for the benefit of the gut microbiome. Unseen Bio, thus, allows users to improve their health through gut microbiome analysis.
Beo Therapeutics advances Oral Therapeutics
Founding Year: 2019
Location: Zurich, Switzerland
Innovate with Beo Therapeutics for Gut Disease Prevention
Swiss startup Beo Therapeutics offers oral microbiome therapies to counteract gut diseases. Its therapeutic solution rebalances the gut microbiome and urate metabolism and pre-empts hyperuricemia-induced diseases through oral chronic administration. Moreover, Beo Therapeutics works selectively with a small fraction of human gut bacteria that are considered safe for human consumption and carry the designation Qualified Presumption of Safety (QPS). This way, Beo Therapeutics increases the treatment outcomes of hyperuricemic patients who have altered gut microbiomes.
MyMicroZoo prepares Gut Microbiota Reports
Founding Year: 2016
Location: Leiden, Netherlands
Partner with Beo MyMicroZoo for Microbiome DNA Analysis
Dutch startup MyMicroZoo leverages a DNA analysis technology to identify the type and amount of bacteria in the large intestine. Its 16S profiling analysis of gut microbiomes provides an overview of results in a detailed gut microbiota report along with an interactive results dashboard. MyMicroZoo’s test also provides information on the composition, enterotype, diversity, and desired and undesired bacteria of the gut. The data from the test lets health professionals to better interpret results and also provides treatment recommendations.
ZOE provides Personalized Nutrition Programs
Founding Year: 2017
Location: London, UK
Use ZOE’s Solution for At-Home Gut Bacteria Test Kit
UK-based startup ZOE provides at-home gut microbiome test kits that use shotgun metagenomics sequencing to identify a panel of 15 ‘good’ and 15 ‘bad’ types of microbes associated with ‘good’ and ‘bad’ markers of health, along with the users’ preferable foods. This information is then used to create a ZOE Microbiome Health Score that provides comprehensive personalized nutrition advice. Hence, ZOE’s solution enables the users to understand and predict their metabolic responses to foods.
Notitia Biotechnologies build a Microbiome R&D Platform
Founding Year: 2019
Location: Monmouth Junction, USA
Collaborate with Notitia for Gut Health Restoration
US-based startup Notitia Biotechnologies develops Foundation Guild, a microbiome R&D platform. Its proprietary data analysis pipeline allows researchers to study the members of the guild at the strain level and examine their relationship. This enables researchers to discover new bacteria with the potential to improve human health. Further, the platform allows them to analyze and adjust guild bacteria in each individual. For this, the startup tests fecal samples to predict microbiome status and then grows the guild extracted from the sample. Based on that, Notitia Biotechnologies creates formulas like BM306 and NM108 for human consumption that replenishes guild health.
Where is this Data from & how to Discover More Healthcare Startups?
Staying ahead of the technology curve means strengthening your competitive advantage. That is why we give you data-driven innovation insights into the healthcare industry. The insights of this data-driven analysis are derived from our Big Data & Artificial Intelligence (AI)-powered StartUs Insights Discovery Platform, covering 2 093 000+ startups & scaleups globally. The platform gives you an exhaustive overview of emerging technologies & lets you scout relevant startups within a specific field in just a few clicks. To explore healthcare technologies in more detail, let us look into your areas of interest. For a more general overview, download our free Healthcare Innovation Report to save your time and improve strategic decision-making.
